Objective: To report the results of the policies and procedures subsection of a nationwide electroconvulsive therapy (ECT) survey: Canadian Electroconvulsive Therapy Survey/ Enquête canadienne sur les electrochocs.
• While the majority of sites did not feel that a routine second psychiatric opinion was required, there may be certain cases in which this is warranted, such as with patients whose capacity to consent for ECT is in question or with those who are involuntarily hospitalized.
• An ECT accreditation service, whether developed nationally or provincially, could be helpful in auditing ECT practice and ensuring standards of care are met.
Limitations
• Thirty-nine per cent of the 175 ECT centres did not respond to this national survey.
• The quality of our data is limited by the self-report methodology we used, which is less rigorous than an audit of actual practices.
• The survey reflects ECT practice in 2007-2008; however, no revisions of ECT CPGs has taken place since then, hence there is an assumption that ECT practice, as captured with this subsection of the survey on policies and procedures, is not believed to have changed significantly.
A remarkably effective treatment for a range of mental disorders, particularly major depressive disorder, 1 ECT can be safely and effectively administered as an outpatient procedure. 2 Likely as a result of the anti-ECT backlash occurring around the early 1970s, the first evidence-based, comprehensive ECT CPG was published in 1978 by the APA Task Force on ECT. 3 Since then, numerous CPGs or ECT reviews have been published worldwide, notably in commonwealth countries such as the United Kingdom, Australia, and New Zealand. 4, 5 In the United States, the current APA ECT CPGs 6 are being revised again. In Canada, regional CPGs have been formally developed in the province of British Columbia and a national position paper from the CPA was written in 1980, updated in 1992 and 2010, and covers the scope of national ECT practice. 7 In the United Kingdom, there is further evolution owing to the Royal College of Psychiatrists-supported ECT Accreditation Service launched in 2003, which has inspected or audited those UK ECT sites that voluntarily requested accreditation. 8 An independent service exists in Scotland. 9 Little is known about ECT policies and procedures governing the provision of this treatment by Canadian providers. Institutional policies and procedures are often based on existing CPGs. These policies guide important aspects in ECT procedures, such as documentation, the process of consent, including the educational materials given to patients and families, the prescription of ECT before and during a course, peri-anesthetic care, and the adjustments to concurrent medications.
Because of the stigma surrounding ECT and the prospect of some degree of amnesia for the period of treatment, the specifics of the consent process are particularly important, even for people who are psychotically or severely depressed. 10, 11 An earlier Canadian study 12 noted that a second psychiatric opinion should be considered essential when the involuntary patient has been deemed incapable of consent for ECT, and discussions with patients should be clearly documented.
Our paper sought to examine the application of ECT policies and procedures at Canadian ECT centres.
Methods
The first paper published by the CANECTS/ECANEC Associates fully describes the methodology of the survey. 13
Résultats : Soixante et un pour cent (107/175) des institutions ont renvoyé les questionnaires du sondage. La plupart (84 %) des répondants ont une politique générale écrite pour l'administration d'ECT. Seulement 27 % des répondants ont indiqué disposer d'une politique écrite pour la prise en charge des médicaments concurrents durant l'ECT, et la pratique variait beaucoup en ce qui concerne les psychotropes individuels. Le consentement éclairé était habituellement obtenu par le médecin traitant (88 %), et la plupart des centres indiquaient transmettre l'information avant l'ECT en utilisant des moyens interdisciplinaires et multimodaux. Presque tous les centres (93 %) donnaient congé aux patients externes qui devaient être accompagnés d'un adulte responsable.
Conclusions : Il est rassurant de savoir que des politiques et procédures générales d'ECT existent dans la plupart des centres canadiens d'ECT. Des variations de la pratique plus accusées ont été observées dans plusieurs domaines, comme les éléments du consentement éclairé fournis aux patients et familles, l'utilisation de médicaments concurrents, et le degré de supervision après le congé signifié aux patients externes d'ECT. Cependant, l'observance de ces politiques n'a pas été saisie par les résultats de l'enquête. D'après les expériences d'autres pays, la création d'un service d'agrément canadien des ECT pourrait améliorer encore les normes de la pratique.
Briefly, a comprehensive questionnaire was developed and mailed to ECT administrators and coordinators of the 175 institutions providing ECT in Canada in 2007. The covering letter asked for interdisciplinary input to complete pertinent sections. The final versions (French and English) of the questionnaire, which consisted of 76 questions, included 12 questions pertaining to policies and procedures (online eAppendix 1). These questions can be divided into 3 broad categories: policies and procedures existing within an institution (7 questions), those concerning the consent process (4 questions), and 1 focused on possible changes in concurrent medications during ECT.
Results
Among the 175 ECT centres identified, 107 sites responded, yielding a response rate of 61%. The figures and table show the number of responding sites for each survey question. Nonreporting sites were not significantly different from the reporting sites on measures such as bed count size and catchment population. 13 Most (84%) of the responding sites have a written general policy for the delivery of ECT, while 78% have a written policy for nursing ( Figure 1 ). Fewer than 50% of the sites have a written policy for psychiatry or other medical staff, electrode placement, or electrical dosing. Regarding anesthesia, 29% of sites reported having a policy, but this figure may be an underestimate as this section of the survey was filled out by staff other than anesthesiologists. The majority of responding sites (64%, n = 66) followed some CPGs closely (Table 1) , and were influenced by either the APA guidelines, 6 the British Columbia guidelines, 14 the United Kingdom handbook, 4 or a combination of these. For the 9% of sites that followed CPGs closely and indicated that they used some other document, some respondents indicated in the survey comment section that the 1992 CPA position paper 15 on ECT was used. However, this national position paper, although applicable to Canadian practice, is not a CPG and was considered in need of revision at the time the results of our survey were received in 2007-2008.
A pre-ECT medical evaluation was carried out at all sites, with the responsibility for the evaluation divided among The Canadian Survey of Standards of Electroconvulsive Therapy Practice: A Call for Accreditation general practitioners (36%), anesthesiologists (36%), and the treating psychiatrists (25%). At 3% of the sites, other personnel, such as an internist, provided the evaluation. Data from the anesthesia section of this survey indicated that anesthesiology consultation was considered mandatory at 61% of the sites, but in this section of the survey only 36% stated that this would be the primary medical evaluation pre-ECT (n = 92 responding sites). "patients must be accompanied home and monitored for the rest of the day by a responsible adult" (45%). Seven per cent allowed "travel independently (but not driving home)." Six per cent followed some "other policy," but these sites all indicated in the comment section that they discharge home with a responsible adult (with varying degrees of supervision).
In the matter of informed consent, it was reassuring to see that all sites indicated that the treating physician discussed ECT with the patient and (or) family ( Figure 2 ), and informed consent was usually obtained by the attending physician (88%) or the ECT practitioner (9%), as shown in Table 1 . Moreover, as shown in Figure 2 , the vast majority also had discussions with allied health professionals, and obtained information from a brochure and (or) video. Other sources of information reported by respondents included having the opportunity to speak to a volunteer ECT consumer, access to a binder with pictures and information, access to an education group with other patients and facilitated by nursing, and a tour of the ECT suite. Regarding information conveyed in the consent form, the 6 elements listed in Figure 3 reflect APA Task Force on ECT guidelines; although treatment alternatives and "no guarantee that ECT will be effective" were discussed less often than the other 4 items, the majority of sites, nevertheless, did discuss these elements.
About two-thirds of the sites indicated that a routine second psychiatric opinion was not required, and in those (n = 39) where it was required, 69% did so at the start of treatment and 31% did so at some other time. A subanalysis indicated that second opinions were more likely to be obtained routinely in nonteaching (n = 76) rather than teaching (n = 31) sites, and in higher-volume (600 or more treatments per year) facilities. For the transition to maintenance ECT, 85% of respondents indicated continuing documentation of consent, with more than 82% stating some written form of documentation (Table 1 ). Written formal documentation was more likely at teaching sites.
Only 27% of respondents reported having a written policy for managing concurrent medications during ECT ( Figure  1 ). Generally, pre-ECT antipsychotic and AD dosages were unchanged, except for MAOIs, which were discontinued at 73% of the sites (Figure 4 ). The response rates for managing lithium and anticonvulsants were similar, with most discontinuing these medications before and during ECT.
Discussion
The CANECTS/ECANECT survey was the first comprehensive national ECT survey conducted in Canada. There was a reasonably high response rate of 61% of the total identified 175 Canadian ECT centres. The response rate was comparable across the regions of Canada (except the Territories, where no ECT centres were identified). This response rate compares very favourably with the average rate in empirical studies conducted within the behavioural and managerial sciences when data are voluntarily gathered from organizations. 16 It compares favourably with other national ECT surveys, [17] [18] [19] [20] [21] [22] which reported response rates ranging from 51% to 100%. Previously, there has only been 1 small survey of selected hospitals across Canada published in 1984, focused on provincial use rates (mainly derived from health databases), and only a small number of the 14 respondents indicated that they followed some local ECT practice guidelines. 23
General Policies and Procedures Existing Within an Institution
It is reassuring that most of the institutions had general and nursing written policies concerning ECT. It seems likely that adherence to existing CPGs influenced policy development, considering that 64% of centres reported that they followed guidelines closely, despite the absence of Canadian CPGs for ECT. Fewer than one-half of the respondents had policies on electrical dosing and electrode placement, but it is possible that there are existing informal agreements between ECT practitioners at an institution on these issues, which were not written out formally. This is comparable with the finding by Duffett and Lelliott's 24 audit of 55 sites in England and Wales, in which 67% lacked any clear written stimulation policies despite being recommended by the UK's Royal College of Psychiatrists' handbook at the time. 25 However, for the series of Scottish audits of 36 sites over a 3-year cycle, 9 100% had developed a stimulus dosing protocol by the end of that cycle, which demonstrated that scrutiny can influence policy development. The ECT accreditation services launched in the United Kingdom 8, 9 have now audited many sites, 26, 27 and have established numerous standards, including requirements for regular review of ECT policies, and local protocols for stimulus dosing. In the Netherlands, a national postal survey 22 showed that over 90% of facilities adhered to a local protocol describing the responsibilities of various personnel, and also adhered to a stimulus dosing range by the second session. National surveys in other countries, such as Australia, 19 Belgium, 21 and Norway, 20 did not comment specifically on the existence of, or adherence to, written policies and procedures. However, note that in certain parts of Australia, there is a mandatory requirement for written policies and procedures as part of licensing, or relicensing, an ECT facility. 28 The results of our survey suggest that the quality of ECT administration might be enhanced by developing stimulus dosing and initial electrode placement procedures within individual facilities, in view of the heterogeneity of practice in these parameters and the frequent practice of having multiple ECT practitioners deliver ECT during a series for any individual patient. Based on its success in the United Kingdom, repeated ECT audits to standardize care might be considered as a future step in Canada, and formulating Canadian CPG could provide a template for developing institutional policies and measuring adherence to them.
As expected, all respondents indicated that a pre-ECT assessment was done by a physician. Given the frequent comorbidities in patients referred for ECT, one might expect a relatively high demand for pre-ECT anesthesia consultation. In our survey, 61% of sites indicated mandatory consultation, which is higher than the 23% found in a recent United Kingdom postal survey of 62 responding anesthesiologists. 18 As a lack of anesthesiologist time is considered to be a human resource barrier in over one-half of the sites, 13 there needs to be a balance struck in many centres between best practice and undue delay in getting the ECT started because of a lack of consultation resources. Clearly, as stated in some CPGs 4,6 there are certain clinical conditions elevating the risks of ECT that would warrant mandatory consultation by an anesthesiologist, beyond routine medical evaluation.
Intertreatment monitoring of patients undergoing an index course is suggested in the APA CPGs 6 as "after every 1 to 2 treatments" p 203 and in the CPA ECT position paper 7 as "at least weekly." p 5 In our survey, the majority of responding sites adhered to these guidelines by monitoring after each treatment in the case of new treatment orders. For the sites indicating waiting for numerous treatments, the mean number of 3.4 treatments is compatible with weekly monitoring only if thrice-weekly ECT is ordered.
There was some variation in practice regarding the discharge policy after ambulatory ECT, which probably reflects lack of clarity about what constitutes the standard of care after a short procedure, such as ECT, under general anesthetic. The CAS 2011 revised Guidelines to the Practice of Anesthesia state " . . . the necessity for attention by a competent adult for the postoperative period (most commonly 24 hr postoperatively)," 29, p 83 while the American Society of Anesthesiologists recommends " . . . as part of a recovery room discharge protocol, requiring that patients have a responsible individual accompany them home after discharge." 30, p 747 The APA CPG recommends that the patient " . . . leave the facility in the care of a significant other or caregiver." 6, p 195 In our survey, 93% had a responsible adult accompany the patient home, but only 45% required the adult to monitor for the rest of the day, thus that adherence to practice guidelines is relatively poor if the CAS guidelines are followed. It is of concern that 7% of sites allowed independent travel (except driving) post-ECT, in contravention to these published guidelines, while another 5% employed some other discharge policy. The overall results speak to the difficulty sometimes encountered in finding a responsible adult who can escort the patient up to 24 hours post-ECT, and is cited as one of the most common logistical barriers in this survey. 13 In the United Kingdom, the guidelines appear more stringent and adhered to by numerous sites.
In the UK postal survey of anesthesiologists, 18 86% of sites adopted the ECT Accreditation Service guidelines, 31 which includes the recommendation of an accompanying adult directly supervising for 24 hours. In Canada, more explicit guidelines related to supervision post-ECT would offset some of this variation in practice. Although the general anesthetic given for ECT is relatively short acting, the nature of the ECT procedure and the ensuing post-ictal recovery period distinguishes it from other medical or surgical outpatient procedures in which general anesthetics are used, and that can argue for lengthened supervision by a responsible adult.
Policies and Procedures for Informed Consent
Our findings show that information about ECT was commonly conveyed to patients and families through multimodal and interdisciplinary means. The survey did not request specific information on the type of brochure or ECT video that was shown, and on the currency of these materials. It also did not ask about the use of Internet resources, which can provide some helpful information but can also be misleading or anti-ECT in nature. Conveying ECT information in the consent process is important, as it can enhance decision-making capacity in younger 11 and older adults, 10 although not always so. 32 There are some advantages in designating the primary attending physician as the one to obtain consent (as practiced in 88% of sites), as the attending physician has an established therapeutic relationship with the patient. However, there may be disadvantages if the attending physician is not as knowledgeable about ECT as the ECT practitioner, or if the attending feels uncomfortable discussing the subject with the patient and their family. The ECT practitioner is likely in a better position to evaluate a patient's capacity to consent. Delegating patient consent to a nurse is not regarded as a good standard of care, and the survey showed, fortunately, that this was a rare practice. Delegating to residency staff is also not usually preferable in Canada, because of the perception of inadequate training in ECT. 33 Whether one is a member-in-training, an attending physician, or an ECT practitioner, the skills needed to obtain informed consent and allaying fears surrounding treatment are perhaps equally important to the technical skills for the treatment itself. Conveying the important elements of consent was implemented by the majority of sites, but not consistently by all. Optimizing the process for informed consent for ECT is also paramount in view of the literature on perceived coercion by people who consented to ECT but felt pressured into doing so. In reviews on this topic, up to one-half of ECT patients had a poor understanding of ECT and up to one-third felt coerced. [34] [35] [36] [37] Therefore, a second psychiatric opinion may be warranted in some cases, particularly if a patient is involuntarily detained but deemed capable by attending staff to consent to ECT, as reflected by qualitative comments in our survey. Routine second psychiatric opinions were performed in few of the sites responding. Some may view this practice as ideal, while others may consider it simply unnecessary. Larger ECT centres were more likely to require second opinions, a practice supported by the greater availability of ECT practitioners. In rural or remote areas of Canada, obtaining a second psychiatric opinion may be difficult and could potentially constitute a barrier to starting ECT if this were mandated routinely.
Policies and Procedures for Concurrent Medications
Practices regarding the prescription of concurrent medications during ECT were, as expected, variable. Only about one-quarter of responding sites had some policy or procedure concerning this issue. The results are viewed with respect to adherence to existing CPGs and key review papers in this area.
There was a clear tendency to continue antipsychotics at pre-ECT dosages, and discontinue or decrease benzodiazepines. This is consistent with APA, 6 British Columbia, 14 and UK 4 CPGs. It is acceptable to continue antipsychotics, although one needs to be cautious with clozapine because of its seizureinducing potential, and it is best to taper the latter if feasible. 4 For ADs, most (79%) respondents indicated continuing at pre-ECT dosages, whereas the converse (20%) was reported for continuing irreversible MAOIs. In general, ADs are considered safe to administer during ECT, and may even augment ECT response rates when started at the beginning of ECT. 38 However, the question that our survey raises is whether one should continue the same AD at the same pre-ECT dose if the patient had relapsed on that AD before the initiation of ECT; the medication-resistant patient is at particular risk for relapse after ECT. 39 Some studies noted lower relapse rates when there is a switch to a tricyclic AD for maintenance pharmacotherapy post-ECT. 40, 41 It is somewhat surprising that MAOIs would be discontinued as several CPGs do not recommend discontinuation of MAOIs during ECT unless necessary. 4, 6, 14 Moreover, numerous studies or case reports have documented the safety of MAOIs with ECT and the anesthetics used for ECT. 42 We can speculate that MAOIs were generally discontinued owing to unfounded worries that an adverse event may occur during the treatment, particularly by augmenting a hypertensive response during and just after ECT.
Finally, the survey results indicated that the practice for lithium and anticonvulsants was heterogeneous across respondents, but similar in rates of decreasing or discontinuing the medication in the comparison between the 2. Concerns have been raised in the past that ECT and lithium may potentiate cognitive impairment or prolong neuromuscular blockade, especially with higher levels of lithium, but a recent review concluded that lithium can be administered safely during a course of ECT. 43 In general, discontinuing or maintaining lower serum therapeutic levels of lithium is suggested, 6, 14, 44 and most (82%) of the respondents indicated that they followed this guideline. Because anticonvulsants can alter seizure expression during ECT, the APA CPG, 6 for example, recommends tapering off if prescribed for psychiatric reasons alone. Most respondents to the survey (85%) decreased the dose or discontinued anticonvulsants.
Conclusions
Establishing CPGs to guide the development of an institution's policies and procedures is a substantial step toward translating knowledge into practice. It is reassuring that general ECT policies and procedures do exist in most Canadian ECT centres. However, adherence to these policies and procedures is not known and is not captured by our survey. Wider variations in practice were observed in several areas, such as the elements of consent provided to patients and families, the use of concurrent medications, and the degree of supervision on discharge home after outpatient ECT. This may result from a lack of adherence to policies and procedures, or may represent the lack of clarity on what constitutes best practice in these areas. Establishing a Canadian ECT accreditation service can further improve standards of practice.
